VERIFIEDThird-party laboratory
Lot PR-2608-TR30
Tirzepatide 30mg — 30 mg per vial
- Product
- Tirzepatide 30mg
- Batch
- PR-2608
- Lot
- PR-2608-TR30
- Specification
- 30 mg per vial
- Identity result
- Tirzepatide confirmed
- Identity method
- LC-MS (mass confirmation)
- Purity result
- 99.887%
- Purity method
- HPLC-UV
- Assayed content
- 32.37 mg
- Laboratory
- Independent third-party analytical laboratory
- Test date
- 20 August 2026
Reported analytes
| Analyte | Assayed content |
|---|---|
| Tirzepatide | 32.37 mg |
Scope note
Analysed as a blind test across the common GLP-1 analogues.
Certificate
The analytical values on this page are transcribed from the third-party report held on file. A downloadable certificate is published once an unbranded copy is issued; request the report for this lot from orders@peptideresearch.au.
Linked record
View the catalogue record